Summary As integration of leprosy control programmes proceeds, general health staff will have responsibility for the diagnosis of most new cases of leprosy. The training required by these workers has not yet been set out in detail. In this paper the criteria for making the diagnosis of leprosy in the AMFES cohort of 594 new cases are examined. Since this study does not include details of suspects in whom leprosy was excluded on clinical grounds, true sensitivity and specificity values cannot be calculated, but the positive predictive value of the diagnostic criteria can be measured. Sensory loss in a typical skin patch is the most important sign of early leprosy, but was not present in 132 (49%) of the 268 cases with a positive skin smear. Thickening of the ulnar nerve is a valuable sign of leprosy in Etruopia. It can be taught to health workers, who can practise by examining their own ulnar nerves. It is more likely to be present than nerve function impairment and is particularly important when skin smears are difficult to do or are unreliable. We recommend that five basic signs are used, the presence of any two being diagnostic of leprosy:
The major disadvantage anticipated, however, is the lack of specialized skills in these general health workers, who have to manage a variety of conditions and for whom leprosy will usually be a rare problem. Those involved in the training of health staff have expressed concern about defining a basic curriculum related to leprosy, which would not overload the trainee, but which at the same time would provide a sound basis for the management of the cases being seen. [3] [4] [5] This paper looks at one aspect of a basic curriculum, namely the diagnosis of leprosy and what would be the simplest message to teach general health workers. The objective of such training would be to enable them to suspect leprosy and either make the diagnosis themselves in a reliable manner, or refer the case to someone with more experience.
Traditionally, three cardinal signs have been used to diagnose leprosy, 6 namely:
1. Definite loss of light touch sensation in a skin lesion consistent with leprosy. 2. Skin smears positive for acid-fast bacilli.
3. Thickening of one or more peripheral nerves.
These signs have not been extensively tested for sensItIvIty, specificity and inter observer agreement, and studies that have been published give equivocal results. 7 -9 Current WHO guidelines, however, advocate the use of only two cardinal signs, num bers 1 and 2 above, 1 O either one being sufficient to make the diagnosis of leprosy.
These guidelines further state that: 'nerve damage, mainly to peripheral nerve trunks, constitutes another feature of leprosy. There may be loss of sensation in the skin and weakness of muscles supplied by the affected nerve. In the absence of these signs, nerve thickening by itself, without sensory loss and/or muscle weakness is often not a reliable sign of leprosy.' The role of nerve thickening in the diagnosis of leprosy is made clear in the seventh report of the WHO Expert Committee on Leprosy, II which stated that 'the disease should not be diagnosed if only nerve thickening is present, without any other accompanying symptoms or signs. ' We decided to examine the criteria for the diagnosis of leprosy in a large prospective study being carried out in Ethiopia, in order to determine what may be the most appropriate diagnostic criteria for use by peripheral health staff.
Patients and methods
Unselected new cases were enrolled in the AMFES project (ALERT MDT Field Evalua tion Study) between March 1988 and March 1993. 1 2 For a variety of reasons related to deeply held cultural beliefs and practices, patients with leprosy in central Ethiopia have generally presented very late for diagnosis; signs of nerve involvement are therefore rather common in this group. 1 3 Detailed records of the clinical signs at diagnosis were available for analysis.
The following details for each case were analysed:
• Skin smear result.
• The number of skin lesions.
• The presence of loss of sensation in a skin lesion, tested with a wisp of cotton wool.
• The presence of nerve function impairment, based on the testing of four muscles for power, using a three-point scale of strong/weak/paralysed (eye closure, fifth finger abduc tion, thumb abduction and dorsiflexion of the foot) and 10 points on each palm and sole for loss of touch sensibility, using a 10 g nylon monofilament. Details of any loss of muscle power and any loss of touch sensibility were recorded.
• The presence of visible damage to hands or feet (who impairment grade 2). 14 • The presence of thickening in any of six nerves examined (greater auricular, ulnar, median, radial cutaneous, peroneal and posterior tibial).
• Skin biopsy results for certain patients.
Results
In all, 603 new cases were enrolled in AMFES . Nine patients were excluded on the grounds of incorrect diagnosis (three cases) and incorrect enrolment procedures (6 cases), leaving 594 cases for the current analysis.
Biopsies were performed for 10 cases in whom the diagnosis on clinical grounds (usually typical skin lesions without sensory loss) was suggestive but not certain. Leprosy was confirmed in nine cases (90%). Biopsies were also done on a random sample of 102 patients whose diagnosis was not considered doubtful by experienced field staff. Leprosy was confirmed in 100 of these cases (98%). Figure 1 shows how the traditional cardinal signs of leprosy contributed to the diagnosis in 594 AMFES patients. In this analysis, thickening in any of six nerves was taken into Traditional criteria for the diagnosis of leprosy (AMFES). n = 594; 17 cases are undiagnosed using these criteria. The ulnar and radial cutaneous nerves were the most commonly involved, as shown in Table l . The one case diagnosed by the finding of a thickened nerve, but without thickening of either the ulnar or radial cutaneous nerves, had a grossly thickened median nerve and some loss of fu nction of the ulnar nerve.
Because of the very frequent involvement of the ulnar nerve and the relative ease with which it can be examined, Figure 2 looks at the effect of using only that nerve for diagnostic purposes. . n = 594; 23 cases are undiagnosed using these criteria.
had sensory loss, while only 160 (52%) had loss of muscle strength. By examining sensory loss and loss of muscle strength as two different criteria, it is found that sensory loss is a much more sensitive diagnostic tool; if both tests are used, loss of muscle strength contributes very little, with only one additional case being diagnosed. The simplest group of signs with the maximum yield in this patient population consists of four criteria, as shown in Figure 4 , with any one sign being strongly suggestive of leprosy:
• A skin smear positive for acid-fast bacilli.
• Sensory loss in a typical skin lesion.
• Loss of sensation anywhere in the palms of the hands or soles of the feet.
• Thickening of one or both ulnar nerves.
The most worthwhile addition to this battery of tests would be to add thickening of the radial cutaneous nerve: three additional cases would be diagnosed, bringing down the number of undiagnosed cases to 14. Voluntary muscle testing and an assessment of damage to the hands and feet (WHO impairment grade 2) would add very little to the diagnostic process, even in this cohort with relatively high rates of impairment at diagnosis.
Discussion
When proposing diagnostic criteria for any medical condition, the sensitivity, specificity and predictive values of the criteria are important considerations. Table 2 shows how these terms are defined and calculated. In leprosy, a test with low sensitivity will mean that new cases are missed, with the possible outcome of permanent nerve damage, disability and deformity. Low specificity, on the other hand, will lead to overdiagnosis and the unnecessary labelling Figure 4 . The use of four basic signs for the diagnosis of leprosy (AMFES). n = 594; 17 cases are undiagnosed using these criteria.
of some people as leprosy patients, still associated with varying degrees of stigma in many cultures. For a rare condition, such as leprosy now is in most countries, the specificity of a diagnostic test must be very close to 100%. If the specificity is much less than this, there will be many false positives and a large proportion of the patients diagnosed would not actually have the disease: in other words the positive predictive value of the test would be very low. In practice, the positive predictive value of diagnostic tests in this situation is improved by pre-selection of cases: 15 for leprosy, clinic attenders with suggestive skin lesions are pre-selected to undergo the more formal diagnostic tests and the prevalence of leprosy will be much higher in this group than in the general population.
The specificity of a diagnostic test can only be measured when a large number of suspects are examined and the proportion of false positives is calculated. The gold standard for determining the actual status of each subject (leprosy: yes or no) is difficult to define, but is likely to include a combination of expert clinical opinion and histopatho logical examination.7 As the present study neither took biopsies nor recorded details of suspects who were examined and thought not to have leprosy, it is impossible to calcu late the specificity of this battery of diagnostic tests from this dataset. However, in those cases biopsied as a random check of the accuracy of the clinical diagnosis, only 2% were found to be falsely positive, indicating a positive predictive value of 98% in this setting.
In this cohort, cases missed by the various diagnostic regimens described, range from 14 to 23 out of a total of 594 new cases. This difference may well be smaller than the errors to be expected in any routine programme. The field staff in the AMFES project were very experienced and worked in a vertical programme, so that their performance may not be reproducible in a general clinic. On these grounds, therefore, any of the methodologies described would be acceptable in terms of sensitivity.
The skin smear is the only part of the diagnostic process which is outside the direct control of the primary healthcare worker. Given appropriate training and motivation, (s)he can carry out all the other diagnostic steps. In many programmes, therefore, it is not surprising that the skin smear is the weak link and many leprosy suspects may wait a long time for a smear result, or never have the possibility of a skin smear at all.
Using the traditional diagnostic criteria (Figure 1) , there are only 10 patients diagnosed solely by a positive smear, while 478 (80%) of patients are diagnosed by at least two criteria. If the number of nerves examined is reduced to one (Table 1, Figure 2) , the figures are not greatly changed. Using the new WHO guidelines (Figure 3) , 65 patients are diagnosed by smear alone, while only 346 (58%) are diagnosed by at least two criteria. The addition of ulnar nerve thickening as a diagnostic sign (Figure 4 ) greatly improves the possibility that two signs are available to suggest the diagnosis of leprosy. This could be an important consideration in areas where smears are not available.
Similar data have been published from Bangladesh in a study which examined the classification of new cases.16,17 A total of 244 consecutive new cases were diagnosed clinically, with skin smears and biopsy. It was found that 32% had positive skin smears, 77% had loss of sensation in a skin lesion, 90% had enlarged nerves and 54% had nerve function impairment; of the 32 cases not confirmed by biopsy or skin smears, 24 had loss of sensation in a skin lesion, seven had enlarged nerves and one had nerve function impairment. No combined figures are available, since data were collected for classifica tion purposes, not diagnosis, but the similarity with the AMFES data as illustrated in Figures 1 and 3 , is striking.
The reliability of thickened nerves as a sign of leprosy was first questioned in Nepali army recruits, 63% of whom had thickened greater auricular nerves. 18 It was suggested that well-developed musculature could lead to enlargement of the related nerve, an effect noted in the ulnar nerves of another group of manual workers. 19 However, in a detailed clinical and histological study, Srinivas et al. found that in a carefully selected group of suspects with nerve enlargement but no other clinical sign of leprosy, five of 16 (3 1 %) had leprosy, two had diabetic neuropathy and nine were labelled as idiopathic neuropathy.2o
In a large population survey in Malawi, the sensitivity and specificity of the cardinal signs of leprosy were examined: 95% of the cases diagnosed were early paucibacillary cases. 7 It was noted that amongst self-reporting new cases in Malawi, 49·5% had definite nerve enlargement, while the figure was only 19·2% for actively detected cases. Definite nerve enlargement was said to make the diagnosis of leprosy 'extremely likely', although it contributed to the diagnosis in only a minority of cases of paucibacillary disease. It is interesting that in the same survey, sensory loss in skin lesions was found unsatisfactory as a diagnostic test with a sensitivity of 48·5% and a specificity of 72%. The conclusion of the Malawi study was that the diagnosis of very early leprosy is so uncertain by clinical methods alone that such a total population survey should not be undertaken without the help of histopathology.
In the cohort presented here, nerve enlargement is shown to be a valuable sign in skin smear positive cases. These patients may have poorly defined skin lesions, which often do The first two features are, in fact, double signs. We propose splitting them into their component parts, making five signs of leprosy, any two of which would be grounds to diagnose the disease. This means that a typical case with early lepromatous leprosy, who has skin lesions without definite sensory loss and thickened nerves without impairment, could be diagnosed even if a skin smear result is not available. While a positive skin smear on its own should be enough to diagnose leprosy, it is unlikely to be found without any of the other four signs.
We therefore recommend that those general health staff who are to be responsible for the diagnosis of leprosy should be taught to look for five signs: Finding any two of these signs would be diagnostic of leprosy. The exact policy for diagnosis must be determined by each national programme; it may be necessary to recommend that certain suspects are referred to a specialist for confirmation of the diagnosis. Further research into the sensitivity and specificity of these diagnostic criteria in different endemic countries is needed and the best methods for teaching general health staff remain to be elucidated.
